Prostate Cancer & PSA Tumors News Articles

Prostate Cancer News

PROSTATE ADVISOR

Prostate Cancer News

Men with aggressive prostate cancer who test positive for AR-V7 in circulating tumors cells are unlikely to benefit from treatment with abiraterone or enzalutamide.

Combination Biopsy Strategy May Identify More Prostate Cancers

A lesion visible on magnetic resonance imaging (MRI) identifies a heightened risk for clinically significant prostate cancer in men undergoing first-time prostate biopsy, and a combination of targeted and systematic biopsy may improve the chances of detecting cancer.